Q32 Bio Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Q32 Bio Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • Q32 Bio Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $99.3M, a 662207% increase year-over-year.
  • Q32 Bio Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $184K, a 69.1% decline from 2022.
  • Q32 Bio Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $596K, a 98.9% decline from 2021.
  • Q32 Bio Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $52.2M, a 1.74% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $184K -$412K -69.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 $596K -$51.6M -98.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $52.2M -$924K -1.74% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $53.1M -$105M -66.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
2019 $158M +$7.22M +4.78% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $151M +$35.8M +31% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $115M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.